Search by Drug Name or NDC

NDC 50419-0489-01 Nexavar 200 mg/1 Details

Nexavar 200 mg/1

Nexavar is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Bayer HealthCare Pharmaceuticals Inc.. The primary component is SORAFENIB.

MedlinePlus Drug Summary

Sorafenib is used to treat advanced renal cell carcinoma (RCC; a type of cancer that begins in the kidneys). Sorafenib is also used to treat hepatocellular carcinoma (a type of liver cancer) that cannot be treated with surgery and a certain type of thyroid cancer that has spread to other parts of the body and cannot be treated with radioactive iodine. Sorafenib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply. This helps stop the spread of cancer cells.

Related Packages: 50419-0489-01
Last Updated: 04/14/2024
MedLinePlus Full Drug Details: Sorafenib

Product Information

NDC	50419-0489
Product ID	50419-489_57a88370-996d-4c12-bd30-c934b65b9c9d
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	Nexavar
Proprietary Name Suffix	n/a
Non-Proprietary Name	sorafenib
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET, FILM COATED
Route	ORAL
Active Ingredient Strength	200
Active Ingredient Units	mg/1
Substance Name	SORAFENIB
Labeler Name	Bayer HealthCare Pharmaceuticals Inc.
Pharmaceutical Class	Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]
DEA Schedule	n/a
Marketing Category	NDA
Application Number	NDA021923
Listing Certified Through	2024-12-31

Package

NDC 50419-0489-01 (50419048901)

Pricing Information	N/A
NDC Package Code	50419-489-01
Billing NDC	50419048901
Package	120 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50419-489-01)
Marketing Start Date	2023-10-02
NDC Exclude Flag	N